Zobrazeno 1 - 10
of 70
pro vyhledávání: '"asude aksoy"'
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 59, Iss 1, Pp 1-5 (2023)
Abstract Background Cavernous sinus thrombosis (CST) is a very rare disease and can occur as a result of pharyngitis, a face infection, sinusitis, orbital cellulitis, otitis, traumatic injury, or surgery, particularly if the patient has a thrombophil
Externí odkaz:
https://doaj.org/article/3e0d0e4b3ba044ee9a04c42dae8cf3be
Publikováno v:
Archives of Medical Science, Vol 18, Iss 4, Pp 1123-1126 (2022)
Externí odkaz:
https://doaj.org/article/0a1ee811f1b54cdfac64250e6237e74f
Autor:
Asude Aksoy, Ahmet Tektemur, Elif Melek, Mustafa Kayfeci, Muhammed F. Uslu, Ugurcan Cosar, Ebru Onalan
Publikováno v:
Contemporary Oncology, Vol 24, Iss 4, Pp 241-246 (2021)
Externí odkaz:
https://doaj.org/article/c5c908c48f2a4a30b5f9b1797de0a08e
Autor:
Ali Aksu, Mehmet Buğra Bozan, Nurullah Aksoy, Ayşe Azak Bozan, Nizamettin Kutluer, Burhan Hakan Kanat, Sevim Şenol Karataş, Asude Aksoy, Abdullah Böyük
Publikováno v:
Turkish Journal of Colorectal Disease, Vol 29, Iss 2, Pp 65-68 (2019)
Aim:In this paper, we aimed to evaluate the patients who underwent trephine stoma with sedoanalgesia in addition to local anesthesia and to share the results.Method:The patients who underwent trephine stoma with sedoanalgesia in addition to local ane
Externí odkaz:
https://doaj.org/article/cdb9749c54f7407495cd1f992a6c9258
Autor:
İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik, Devrim Çabuk, Ayşe Gökdurnalı, Özlem Balvan, Yaşar Yıldız, Metin Şeker, Nuriye Özdemir, Burcu Yapar, Özgür Tanrıverdi, Yusuf Günaydin, Serkan Menekşe, Berna Öksüzoğlu, Asude Aksoy, Bülent Erdoğan, M. Bekir Hacıoglu, Erkan Arpaci, Alper Sevinç, Mehmet Atilla Uysal, Sinem İliaz
Publikováno v:
Balkan Medical Journal, Vol 33, Iss 5, Pp 517-524 (2016)
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are treated similarly. Serous/cle
Externí odkaz:
https://doaj.org/article/a941accd41ad4cb09b80b59a161a3f2c
Autor:
Asude Aksoy
Publikováno v:
Genel Tıp Dergisi, Vol 26, Iss 1, Pp 1-7 (2016)
Amaç: Serum albumin, albumin-globulin oranı AGR , nötrofil/lenfosit N/L değerlerinin mide kanseri hastalarında sağkalım üzerine etkileri araştırıldı.Gereç ve Yöntem: Ön çalışma niteliğindeki bu çalışmaya kemoterapi değerlendirm
Externí odkaz:
https://doaj.org/article/3f93b8cfb0874b5a87040b6ea3d2b459
Autor:
Mutlu Hizal, Burak Bilgin, Nail Paksoy, Saadettin Kılıçkap, Muhammed Mustafa Atcı, Seda Kahraman, Merve Keskinkılıç, İrem Bilgetekin, Murat Ayhan, Deniz Tural, Önder Eren, Fatma Nihan Akkoç Mustafayev, Şebnem Yaman, Ali Murat Tatlı, Ertuğrul Bayram, Yasin Kutlu, İsmail Ertürk, Erkan Özcan, Ahmet Gülmez, Mustafa Korkmaz, Baran Akagündüz, Dilek Erdem, Tuğba Akın Telli, Asude Aksoy, Necdet Üskent, Yakup İriağaç, Naziyet Köse Baytemür, Dinçer Aydın, Teoman Şakalar, Hacı Arak, Fatih Selçukbiricik, Yakup Ergün, Taner Korkmaz, Naziye Ak, Çağlar Ünal, Nadiye Akdeniz, Mehmet Alpaslan Özgün, Berna Öksüzoğlu, Bülent Yalçın, İlhan Öztop, Efnan Algın, Abdullah Sakin, Adnan Aydıner, Perran Fulden Yumuk, Mehmet Ali Nahit Şendur
Publikováno v:
Future Oncology. 18:2573-2582
Aims: In this multicenter study, the authors aimed to determine the real-life efficacy and safety of first-line alectinib. Materials & methods: This retrospective trial included advanced-stage, ALK-positive non-small-cell lung cancer patients who wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043d1a22a8f3e83e986a7039a57bac7a
https://doi.org/10.2217/fon-2022-0083
https://doi.org/10.2217/fon-2022-0083
Autor:
Seda Kahraman, Enes Erul, Mustafa Seyyar, Ozge Gumusay, Ertugrul Bayram, Burcin Cakan Demirel, Omer Acar, Sercan Aksoy, Naziyet Kose Baytemur, Elif Sahin, Devrim Cabuk, Gul Basaran, Semra Paydas, Arzu Yaren, Deniz Can Guven, Atike Pinar Erdogan, Umut Demirci, Alper Yasar, İbrahim Vedat Bayoglu, Mutlu Hizal, Burcu Gulbagci, Nail Paksoy, Sena Ece Davarci, Funda Yilmaz, Ozlem Dogan, Sibel Oyucu Orhan, Erkan Kayikcioglu, Ali Aytac, Merve Keskinkilic, Eda Eylemer Mocan, Olcun Umit Unal, Esra Aydin, Hakan Yucel, Deniz Isik, Onder Eren, Basak Oyan Uluc, Melike Ozcelik, Ilhan Hacibekiroglu, Adnan Aydiner, Hacer Demir, Berna Oksuzoglu, Ebru Cilbir, Erdem Cubukcu, Bulent Cetin, Esin Oktay, Cihan Erol, Sadi Kerem Okutur, Nilgun Yildirim, Ali Alkan, Fatih Selcukbiricik, Asude Aksoy, Yusuf Karakas, Gulhan Ozkanli, Berna Bozkurt Duman, Dincer Aydin, Ozgecan Dulgar, Muhammed Muhiddin Er, Fatih Teker, Tugba Yavuzsen, Musa Baris Aykan, Ali Inal, Yakup Iriagac, Nurhan Onal Kalkan, Murat Keser, Teoman Sakalar, Serkan Menekse, Engin Kut, Burak Bilgin, Muge Karaoglanoglu, Veli Sunar, Ozlem Ozdemir, Nazim Serdar Turhal, Nuri Karadurmus, Bulent Yalcin, Mehmet Ali Nahit Sendur
Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4603b0dea982cdc71feb0666817cb5
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
https://avesis.deu.edu.tr/publication/details/6b4454d1-de76-4c63-9dab-2c0deccc7b07/oai
Autor:
Tuğba Başoğlu, Abdullah Sakin, Cihan Erol, Ercan Özden, Devrim Çabuk, Ebru Çılbır, Deniz Tataroğlu Özyükseler, Murat Ayhan, Mehmet Ali Şendur, Mutlu Dogan, Berna Öksüzoğlu, Melek Karakurt Eryılmaz, Özlem Er, Elif Şenocak Taşçı, Neslihan Özyurt, Özgecan Dülgar, Miraç Özen, İlhan Hacıbekiroğlu, İrem Öner, Esma Türkmen Bekmez, Hasan Çağrı Yıldırım, Şuayib Yalçın, Semra Paydaş, Emre Yekedüz, Asude Aksoy, Melike Özçelik, Abdilkerim Oyman, Elvina Almuradova, Bülent Karabulut, Nazan Demir, Murat Dinçer, Nuriye Özdemir, Dilek Erdem, Naziye Ak, Ali İnal, Derya Kıvrak Salim, Gülhan İpek Deniz, Teoman Şakalar, Ahmet Gülmez, Turgut Kaçan, Özlem Özdemir, Özkan Alan, Çağlar Ünal, Yusuf Karakaş, Serdar Turhal, Perran Fulden Yumuk
Publikováno v:
Journal of Chemotherapy. 35:142-149
Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare the efficacy and toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c2284ea2d913751fc2b471ed5ebfcc
https://doi.org/10.1080/1120009x.2022.2073159
https://doi.org/10.1080/1120009x.2022.2073159
Autor:
Pınar Gursoy, Ali Murat Tatli, Dilek Erdem, Erdem Goker, Emir Celik, Nebi Serkan Demirci, Abdullah Sakin, Muhammed Mustafa Atci, Ertuğrul Bayram, Tuğba Akın Telli, Burak Bilgin, Ahmet Bilici, Baran Akangunduz, Sevinç Balli, Ahmet Demirkazik, Fatih Selçukbiricik, Serkan Menekse, Eyyüp Cavdar, Akın Ozturk, Esma Türkmen Bekmez, Serdal Turhal, Sadettin Kilickap, Hasan Çağrı Yildirim, Başak Oyan, Asude Aksoy, Fatma Paksoy Turkoz, Engin Kut, Nuran Katgi, Teoman Sakalar, Murat Akyol, Halil İbrahim Ellez, Atakan Topcu, Atike Pınar Erdoğan, Kezban Nur Pilanci, Engin Hedem, Hacı Arak, Nadiye Akdeniz, Özkan Alan, Burcu Yapar, Deniz Nart, Perran Fulden Yumuk
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:865-875
Objectives: To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20 mutation-positive non-small cell lung cancer (NSCLC). Materials and methods: We retrospectively evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6dfec0cbcbdd9f35f252256f8357168
https://doi.org/10.1007/s00432-022-03984-5
https://doi.org/10.1007/s00432-022-03984-5